{
    "Trade/Device Name(s)": [
        "Dimension Vista MMB Assay",
        "Dimension Vista 1500 System"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K143720",
    "Predicate Device Reference 510(k) Number(s)": [
        "K970343",
        "K051087"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHY",
        "JJE"
    ],
    "Summary Letter Date": "July 31, 2015",
    "Summary Letter Received Date": "August 3, 2015",
    "Submission Date": "September 15, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1215",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system",
        "Analyzer, chemistry (photometric, discrete), For Clinical Use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Mass creatine kinase MB isoenzyme"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista 1500 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "LOCl technology"
    ],
    "Methodologies": [
        "Homogeneous sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "System",
        "Reagent",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Dimension Vista MMB Assay for quantitative measurement of mass creatine kinase MB isoenzyme on the Dimension Vista 1500 System",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative measurement of mass creatine kinase MB isoenzyme in human serum and plasma on the Dimension Vista System for confirmation of acute myocardial infarction",
    "fda_folder": "Clinical Chemistry"
}